The purpose of this study is to evaluate the association of imaging biomarkers from PET/MR with overall survival in pancreatic cancer patients. Sixty-four patients with pathologically-proven pancreatic adenocarcinoma underwent PET/MRI before treatment. The imaging biomarkers included Ktrans and Peak from DCE-MRI, minimal apparent diffusion coefficient from DWI, choline from MR spectroscopy, standard uptake values, metabolic tumor volume, and total lesion glycolysis of the tumors. Among all imaging parameters, Peak was found to be an independent predictor for overall survival in these patients. Thus, the imaging biomarkers from PET/MRI reflect different tumor characteristics and may predict survival outcome in these patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords